نتایج جستجو برای: cgvhd

تعداد نتایج: 422  

Journal: :Blood 2008
Hisaki Fujii Geoff Cuvelier Kevin She Soudabeh Aslanian Hiromi Shimizu Amina Kariminia Mark Krailo Zhengjia Chen Rob McMaster Axel Bergman Frederick Goldman Stephen A Grupp Donna A Wall Andrew L Gilman Kirk R Schultz

Numerous chronic graft-versus-host disease (cGVHD) biomarkers have been identified in limited, single-institution studies without validation. We hypothesized that plasma-derived biomarkers could diagnose, classify, and evaluate response in children with cGVHD. We performed a concomitant analysis of a number of known and predicted peripheral blood cGVHD biomarkers from a Children's Oncology Grou...

2017

Introduction Chronic Graft-versus-Host disease (cGvHD) is a complication of allogeneic hematopoietic stem cell transplantation (HSCT), which diminishes patients’ quality of life (QoL). The oral cavity is often affected, causing mucosal changes (erythema, pseudomembranous ulcerations, lichenoid and hyperkeratotic changes), oral dryness, and sclerosis. Previous studies discussed the signs and sym...

2017
Chien-Ting Chen Chun-Yu Liu Yuan-Bin Yu Chia-Jen Liu Liang-Tsai Hsiao Jyh-Pyng Gau Tzeon-Jye Chiou Jing-Hwang Liu Yao-Chung Liu

Chronic graft-versus-host-disease (cGvHD) is a serious complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Among various organ-specific cGvHD, the cGvHD of liver is less well-characterized. In this study, we applied the National Institutes of Health 2014 scoring criteria of cGvHD to analyze a retrospective cohort of 362 allo-HSCT recipients focusing on cGvHD of liver...

2017
Ahmad Khoder Abdullah Alsuliman Rafet Basar Catherine Sobieski Kayo Kondo Amin Majid Alousi Richard Szydlo Muharrem Muftuoglu Hila Shaim Jane F. Apperley Elif Gokdemir Nichola Cooper Rohtesh S. Mehta David Marin Richard Champlin Elizabeth Shpall Katayoun Rezvani

Chronic graft-versus-host disease (cGvHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). A number of studies support a role for B cells in the pathogenesis of cGvHD. In this study, we report the presence of an expanded population of CD19+CD21- B cells with features of exhaustion in the peripheral blood of patients with cGvHD. CD21- B cells were signif...

2017
Joseph Pidala Tara K Sigdel Anyou Wang Sue Hsieh Yoshi Inamoto Paul J Martin Mary ED Flowers John A Hansen Stephanie J Lee Minnie M Sarwal

Whilst many chronic graft versus host disease (cGVHD) biomarkers have been previously reported, few have been verified in an independent cGVHD cohort. We aimed to verify the diagnostic accuracy of previously reported markers of cGVHD in a multi-centre Chronic GVHD Consortium. A total of 42 RNA and 18 protein candidate biomarkers were assessed amongst 59 cGVHD cases and 33 matched non-GVHD contr...

Journal: :Blood 2014
Ryan Flynn Jing Du Rachelle G Veenstra Dawn K Reichenbach Angela Panoskaltsis-Mortari Patricia A Taylor Gordon J Freeman Jonathan S Serody William J Murphy David H Munn Stefanie Sarantopoulos Leo Luznik Ivan Maillard John Koreth Corey Cutler Robert J Soiffer Joseph H Antin Jerome Ritz Jason A Dubovsky John C Byrd Kelli P MacDonald Geoff R Hill Bruce R Blazar

Chronic graft-versus-host disease (cGVHD) is a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Having shown that germinal center (GC) formation and immunoglobulin deposition are required for multiorgan system cGVHD and associated bronchiolitis obliterans syndrome (BOS) in a murine model, we hypothesized that T follicular helper (Tfh) cells are ...

Journal: :Blood 2004
Kouhei Yamashita Uimook Choi Patricia C Woltz Susan F Foster Michael C Sneller Francis T Hakim Daniel H Fowler Michael R Bishop Steven Z Pavletic Marisa Tamari Kathleen Castro A John Barrett Richard W Childs Gabor G Illei Susan F Leitman Harry L Malech Mitchell E Horwitz

Donor alloreactive CD4(+) T cells are important to the pathogenesis of chronic graft-versus-host disease (cGVHD), but specific subsets of CD4(+) T cells responsible for GVHD have not been defined. We hypothesized that cGVHD might be associated with a preponderance of CD4(+) effector memory cells (CCR7(-)/CD62L(low), CD4(EM)). We analyzed CCR7 and CD62L expression on CD4(+) T cells from stem cel...

Journal: :Blood 2004
Marijke R Canninga-van Dijk Hanneke M van der Straaten Rob Fijnheer Cornelus J Sanders Jan G van den Tweel Leo F Verdonck

Chronic graft-versus-host disease (cGVHD) is an important determinant of long-term morbidity and mortality in allogeneic stem cell transplantation patients. Because cGVHD has clinical, histologic, and laboratory findings of autoimmune diseases and anti-B-cell therapy has shown efficacy in autoimmune diseases, we hypothesized that monoclonal anti-CD20 antibody therapy might improve patients with...

2016
Zinaida Perić Lana Desnica Nadira Duraković Alen Ostojić Dražen Pulanić Ranka Serventi-Seiwerth Ema Prenc Grzegorz Basak Radovan Vrhovac Steven Z Pavletic Damir Nemet

AIM To investigate the ability of two standard quality of life (QOL) questionnaires - The Short Form (36-item) Health Survey (SF-36) and The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ C30) to evaluate QOL in patients with chronic graft-vs-host disease (cGVHD) graded according to National Institutes of Health (NIH) consensus criter...

Journal: :Archives of dermatology 2009
Jason Clark Lawrence Yao Steven Z Pavletic Michael Krumlauf Sandra Mitchell Maria L Turner Edward W Cowen

BACKGROUND Sclerotic-type chronic graft-vs-host disease (cGVHD) of the skin is an uncommon but potentially debilitating sequela of allogeneic hematopoietic stem cell transplantation. There is no standardized assessment measure for this form of cGVHD. Because a full-thickness incisional biopsy specimen to the level of the fascia may be needed to make a definitive histologic diagnosis of cGVHD-re...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید